Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qielan Wu

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Leukocyte Biology|July 21, 2023
HIVEP3 inhibits fate decision of CD8+ invariant NKT cells after positive selectionQielan Wu, Shiyu Bai, Miya Su, et al.
Science China. Life Sciences|April 23, 2026
Artemisinin derivative SM934 targets α-enolase to inhibit PEP-mediated TAK1 stabilization and inflammationJun Pan, Yuwei Zhang, Zhiwei Du, et al.
Frontiers in Immunology|February 6, 2023
Vam6 reduces iNKT cell function in tumor <i>via</i> modulating AMPK/mTOR pathwaysShiyu Bai, Qielan Wu, Shasha Zhu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Leukocyte Biology|July 21, 2023
HIVEP3 inhibits fate decision of CD8+ invariant NKT cells after positive selectionQielan Wu, Shiyu Bai, Miya Su, et al.
Science China. Life Sciences|April 23, 2026
Artemisinin derivative SM934 targets α-enolase to inhibit PEP-mediated TAK1 stabilization and inflammationJun Pan, Yuwei Zhang, Zhiwei Du, et al.
Frontiers in Immunology|February 6, 2023
Vam6 reduces iNKT cell function in tumor <i>via</i> modulating AMPK/mTOR pathwaysShiyu Bai, Qielan Wu, Shasha Zhu, et al.
Pageof 2